Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

B-903

Supelco

Bromazepam solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C14H10BrN3O
Numéro CAS:
1812-30-2
Poids moléculaire :
316.15
Numéro CE :
200-659-6
Numéro MDL:
MFCD00057902
Code UNSPSC :
41116107
Nomenclature NACRES :
NA.24

Qualité

certified reference material

Niveau de qualité

300

Forme

liquid

Caractéristiques

SNAP-N-SPIKE®, SNAP-N-SHOOT®

Conditionnement

ampule of 1 mL

Fabricant/nom de marque

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

Concentration

1.0 mg/mL in methanol

Technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

Application(s)

clinical testing

Format

single component solution

Température de stockage

2-8°C

Chaîne SMILES 

Brc1ccc2NC(=O)CN=C(c3ccccn3)c2c1

InChI

1S/C14H10BrN3O/c15-9-4-5-11-10(7-9)14(17-8-13(19)18-11)12-3-1-2-6-16-12/h1-7H,8H2,(H,18,19)

Clé InChI

VMIYHDSEFNYJSL-UHFFFAOYSA-N

Informations sur le gène

human ... GABRA2(2555)

Catégories apparentées

Description générale

A Certified Snap-N-Spike® Solution suitable for use in LC/MS or GC/MS applications for clinical toxicology, forensic analysis, and urine drug testing. Bromazepam is a benzodiazepine used for the treatment of anxiety.

Informations légales

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Pictogrammes

FlameSkull and crossbonesHealth hazard
GHS02,GHS06,GHS08

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Organes cibles

Eyes

Code de la classe de stockage

3 - Flammable liquids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

49.5 °F - closed cup

Point d'éclair (°C)

9.7 °C - closed cup

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 6

1 of 6

Methaqualone solution 1 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

M-015

Methaqualone solution

(±)-Hydroxybupropion solution 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

H-066

(±)-Hydroxybupropion solution

Phenobarbital solution 1 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

P-008

Phenobarbital solution

Barbital solution 1.0 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

Supelco

B-070

Barbital solution

Etizolam solution 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

E-081

Etizolam solution

Midazolam solution 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

M-908

Midazolam solution

For publication: Tiagabine in the discontinuation of long-term benzodiazepine use.
Panagiotis Oulis et al.
Psychiatry and clinical neurosciences, 63(1), 122-122 (2009-01-22)
D Machado et al.
Revista de neurologia, 49(6), 295-299 (2009-09-04)
To investigate the effects of using bromazepam on the relative power in alpha while performing a typing task. Bearing in mind the particularities of each brain hemisphere, our hypothesis was that measuring the relative power would allow us to investigate
Fernanda Araújo et al.
Neuroscience letters, 496(2), 116-120 (2011-04-23)
This study investigated the effects of bromazepam on qEEG when 14 healthy subjects were asked to perform a visuomotor task (i.e., motor vehicle driving task). The subjects were exposed to two experimental conditions: the placebo (PL) and 6 mg of
Netta Shoenfeld et al.
Harefuah, 150(12), 888-892 (2012-02-23)
Marijuana addiction is one of the most common forms of addiction worldwide. A variety of reasons for use exist, however, there are only a few tested treatments with frequent relapses. In this study, we examined the efficacy of four pharmacotherapy
Gregory Podilsky et al.
European journal of clinical pharmacology, 65(5), 435-442 (2009-02-04)
To characterize and compare the pharmacokinetic profiles of bromazepam, omeprazole and paracetamol when administered by the oral and nasogastric routes to the same healthy cohort of volunteers. In a prospective, monocentric, randomized crossover study, eight healthy volunteers received the three
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique